Retour
Fourchette du Jour
17,39 €
17,96 €
Fourchette 52 Semaines
16,10 €
30,48 €
Volume
1 768 591
Moyenne 50J / 200J
21,38 €
/
22,48 €
Clôture Précédente
17,23 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 101,2 | 0,3 |
| P/B | 6,1 | 3,0 |
| ROE % | 7,5 | 3,7 |
| Net Margin % | 2,2 | 3,8 |
| Rev Growth 5Y % | 97,1 | 10,0 |
| D/E | 1,3 | 0,2 |
Objectif de Cours des Analystes
Hold
33,50 €
+89.1%
Low: 19,00 €
High: 52,00 €
BPA Prévisionnel
-1,12 €
CA Est.
861,52M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
2,48 €
2,15 € – 2,80 €
|
1,54B | 8 |
| FY2029 |
1,50 €
1,30 € – 1,70 €
|
1,37B | 10 |
| FY2028 |
1,18 €
-0,93 € – 7,96 €
|
1,26B | 18 |
No quarterly estimates available
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 97,06% annually over 5 years — strong growth
Generating 45,01M in free cash flow
P/E of 101,18 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 68,60%
Cash machine — converts 201,06% of earnings into free cash flow
Capital efficient — spends only 0,03% of revenue on capex
Croissance
Revenue Growth (5Y)
97,06%
Revenue (1Y)28,46%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
7,48%
ROIC4,85%
Net Margin2,23%
Op. Margin5,52%
Sécurité
Debt / Equity
1,31
Current Ratio3,14
Interest Coverage1,25
Valorisation
P/E Ratio
101,18
Forward P/EN/A
P/B Ratio6,12
EV/EBITDA41,20
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 28,46% | Revenue Growth (3Y) | 59,09% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 97,06% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,00B | Net Income (TTM) | 22,39M |
| ROE | 7,48% | ROA | 2,08% |
| Gross Margin | 89,81% | Operating Margin | 5,52% |
| Net Margin | 2,23% | Free Cash Flow (TTM) | 45,01M |
| ROIC | 4,85% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,31 | Current Ratio | 3,14 |
| Interest Coverage | 1,25 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 101,18 | Forward P/E | N/A |
| P/B Ratio | 6,12 | P/S Ratio | 2,26 |
| PEG Ratio | -1,27 | Forward PEG | N/A |
| EV/EBITDA | 41,20 | Fwd EV/EBITDA | N/A |
| Forward P/S | 2,63 | Fwd Earnings Yield | N/A |
| FCF Yield | 1,99% | ||
| Market Cap | 2,27B | Enterprise Value | 2,28B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,00B | 781,37M | 396,59M | 75,42M | 66,56M |
| Net Income | 22,39M | -197,88M | -528,63M | -652,17M | -746,35M |
| EPS (Diluted) | 0,18 | -1,60 | -4,45 | -6,15 | -8,84 |
| Gross Profit | 901,55M | 663,64M | 338,08M | 69,79M | 61,36M |
| Operating Income | 55,43M | -164,98M | -517,12M | -594,61M | -536,28M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,08B | 885,05M | 788,73M | 760,22M | 881,77M |
| Total Liabilities | 705,11M | 656,51M | 594,21M | 590,35M | 683,10M |
| Shareholders' Equity | 370,15M | 228,54M | 194,52M | 169,87M | 198,66M |
| Total Debt | 486,31M | 469,78M | 110,93M | 112,71M | 210,22M |
| Cash & Equivalents | 467,76M | 411,29M | 351,19M | 551,80M | 640,19M |
| Current Assets | 1,01B | 788,95M | 766,33M | 719,52M | 824,05M |
| Current Liabilities | 323,60M | 185,51M | 247,59M | 167,61M | 131,85M |